EN
登录

C2Sense欢迎eMed Digital Healthcare首席科学官Michael Mina博士加入董事会

C2Sense Welcomes Dr. Michael Mina, MD, Ph.D., Chief Scientific Officer of eMed Digital Healthcare to Board of Directors

CISION 等信源发布 2024-05-28 23:00

可切换为仅中文


WATERTOWN, Mass., May 28, 2024 /PRNewswire/ -- C2Sense, Inc., experts in advanced optical sensing platforms for diagnostic and pharmaceutical applications, announces the appointment of Dr. Michael Mina, MD, Ph.D., to its Board of Directors as an independent director effective May 24, 2024.

马萨诸塞州沃特敦,2024年5月28日/PRNewswire/--C2Sense,Inc.,诊断和制药应用高级光学传感平台专家,宣布任命Michael Mina博士为董事会独立董事,自2024年5月24日起生效。

'We are excited to welcome Dr. Mina, an accomplished industry leader with extensive expertise in infectious diseases, molecular diagnostics and public health to C2Sense's Board of Directors,' said Jason Cox, Ph.D., CEO of C2Sense. 'Dr. Mina will provide strategic and scientific insights across many aspects of our business, including product development and commercialization, as we advance our Halo® suite of customizable readers and algorithms.' .

C2Sense首席执行官杰森·考克斯(JasonCox)博士说,我们很高兴欢迎米纳博士加入C2Sense董事会,米纳博士是一位在传染病、分子诊断和公共卫生领域拥有丰富专业知识的行业领导者Mina博士将在我们推进Halo®可定制阅读器和算法套件的同时,为我们的业务的许多方面提供战略和科学见解,包括产品开发和商业化。”。

Currently serving as Chief Science Officer at eMed Digital Healthcare, Dr. Michael Mina, MD, PhD was an Assistant Professor of Epidemiology at Harvard T. H. Chan School of Public Health (HSPH) and Harvard Medical School. He was a core member of the Center for Communicable Disease Dynamics (CCDD) in the departments of Epidemiology and Immunology & Infectious Diseases at HSPH and Associate Medical Director in Clinical Microbiology (molecular diagnostics) in the Department of Pathology at Brigham and Women's Hospital, Harvard Medical School and was an associate medical director of the Broad Institute of MIT and Harvard's COVID-19 testing laboratory.

目前担任eMed数字医疗保健公司的首席科学官。迈克尔·米纳(MichaelMina)医学博士是哈佛公共卫生学院(HSPH)和哈佛医学院(Harvard Medical School)的流行病学助理教授。他是HSPH流行病学、免疫学和传染病系传染病动力学中心(CCDD)的核心成员,哈佛医学院布莱根妇女医院病理学系临床微生物学(分子诊断学)副医学主任,也是麻省理工学院布罗德研究所和哈佛新型冠状病毒检测实验室的副医学主任。

His research and expertise is focused on the interface of diagnostics, vaccine and infection immunology, and the dynamics of infectious diseases..

他的研究和专业知识集中在诊断学,疫苗和感染免疫学的界面以及传染病的动态。。

Dr. Mina studied at Dartmouth College for his undergraduate degree in engineering and public health. He earned both his M.D. and Ph.D. degrees at Emory University. His Ph.D. was in vaccine immunology and infectious diseases modeling. His postdoctoral work was at Princeton University in mathematical modeling of infectious diseases and in the Department of Genetics at Harvard Medical School where he developed technologies for massively multiplexed immunological profiling.

米娜博士在达特茅斯学院攻读工程学和公共卫生本科学位。他在埃默里大学获得了医学博士和博士学位。他的博士学位是疫苗免疫学和传染病建模。他的博士后工作是普林斯顿大学传染病数学建模和哈佛医学院遗传学系,他在那里开发了大规模多重免疫分析技术。

His medical residency training was in clinical pathology at the Brigham and Women's Hospital in Boston, MA at Harvard Medical School..

他的住院医师培训是在哈佛医学院马萨诸塞州波士顿布莱根妇女医院进行的临床病理学培训。。

Dr. Mina is the recipient of numerous national and institutional awards for his research, including a recipient of the prestigious NIH Director's Early Independence Award. He was identified by the Economist Magazine as one of 8 Global Progress makers for his global health research and not-for-profit work helping bring clean water to rural areas of the world.

米纳博士因其研究获得了众多国家和机构奖项,其中包括著名的美国国立卫生研究院院长早期独立奖。他被《经济学人》杂志认定为全球8位进步者之一,因为他的全球健康研究和非营利性工作帮助向世界农村地区输送清洁水。

He has published over 100 peer reviewed scientific articles and he is on the board of directors or the scientific or medical advisory boards of numerous public and private companies..

他发表了100多篇同行评议的科学文章,并且是众多公共和私人公司的董事会或科学或医学咨询委员会的成员。。

About C2SenseC2Sense is an advanced optical sensing company with a product portfolio that delivers solutions for rapid diagnostics, authentication, and product viability assurance to benefit the health and wellbeing of people worldwide. As an MIT 'Tough Tech' spinout, C2Sense develops products that leverage innovations in optical based sensing to help solve some of the world's toughest challenges.

关于C2SenseC2Sense是一家先进的光学传感公司,拥有一套产品组合,可提供快速诊断、身份验证和产品生存能力保证的解决方案,以造福全世界人民的健康和福祉。作为麻省理工学院的一项“艰难技术”衍生产品,C2Sense开发了利用光学传感创新的产品,以帮助解决世界上一些最严峻的挑战。

For more information on C2Sense, visit www.c2sense.com  and www.haloreader.com..

有关C2Sense的更多信息,请访问www.C2Sense.com和www.haloreader.com。。

SOURCE C2Sense

源C2Sense